On January 16, 2026, the U.S. Supreme Court announced its intent to hear the case of Hikma v. Amarin. This case follows the landmark GSK v. Teva ...

The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...

The high court overturned a ruling that the FDA arbitrarily banned e-cigarette products.

The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drugmaker Hikma that puts so-called ...

On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up ...

The Trump administration has asked a federal court to pause Louisiana's lawsuit challenging the mailing of the abortion drug ...

DOJ accuses Louisiana AG, alleged victim of abortion coercion of trying to "short circuit" FDA's review of mifepristone's ...

The case centered on venue-shopping and whether the tobacco company R.J. Reynolds could appeal in the 5th Circuit appeals court, far from its headquarters.

January would have marked the 53rd anniversary of Roe v. Wade, the 1973 Supreme Court decision that legalized abortion ...

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One analysis found that among 1.88 million patients who had used the drug in the US ...

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has ...